To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
Clinical trial NCT04684485 · COMPLETED
Trial details
- NCT number
- NCT04684485
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2024-11-11
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.